These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12126783)

  • 21. Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes.
    Marre M; Bouhanick B; Berrut G; Gallois Y; Le Jeune JJ; Chatellier G; Menard J; Alhenc-Gelas F
    Hypertension; 1999 Mar; 33(3):775-80. PubMed ID: 10082486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics.
    Azar ST; Zalloua PA; Medlej R; Halabi G
    Endocr Res; 2001; 27(1-2):99-108. PubMed ID: 11428725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease.
    Samuelsson O; Attman PO; Larsson R; Mulec H; Rymo L; Weiss L; Ricksten A
    Nephrol Dial Transplant; 2000 Apr; 15(4):481-6. PubMed ID: 10727542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymorphism I/D of the angiotensin-converting enzyme gene and disturbance of blood pressure in type 1 diabetic children and adolescents].
    Szadkowska A; Pietrzak I; Klich I; Młynarski W; Bodalska-Lipińska J; Bodalski J
    Przegl Lek; 2006; 63 Suppl 3():32-6. PubMed ID: 16898483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
    Penno G; Chaturvedi N; Talmud PJ; Cotroneo P; Manto A; Nannipieri M; Luong LA; Fuller JH
    Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy.
    Matsumoto A; Iwashima Y; Abiko A; Morikawa A; Sekiguchi M; Eto M; Makino I
    Diabetes Res Clin Pract; 2000 Dec; 50(3):195-202. PubMed ID: 11106834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus.
    van Ittersum FJ; de Man AM; Thijssen S; de Knijff P; Slagboom E; Smulders Y; Tarnow L; Donker AJ; Bilo HJ; Stehouwer CD
    Nephrol Dial Transplant; 2000 Jul; 15(7):1000-7. PubMed ID: 10862638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.
    Jacobsen P; Tarnow L; Carstensen B; Hovind P; Poirier O; Parving HH
    J Am Soc Nephrol; 2003 Nov; 14(11):2843-50. PubMed ID: 14569094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme gene polymorphism and glomerular filtration rate changes in type 2 diabetic patients.
    Araz M; Okan V; Celen Z; Aynacioglu S
    Int J Clin Pract; 2002; 56(6):416-8. PubMed ID: 12166538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.
    Jacobsen P; Rossing K; Rossing P; Tarnow L; Mallet C; Poirier O; Cambien F; Parving HH
    Kidney Int; 1998 Apr; 53(4):1002-6. PubMed ID: 9551410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria.
    Felehgari V; Rahimi Z; Mozafari H; Vaisi-Raygani A
    Mol Cell Biochem; 2011 Jan; 346(1-2):23-30. PubMed ID: 20830509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM.
    Nagi DK; Mansfield MW; Stickland MH; Grant PJ
    Diabet Med; 1995 Nov; 12(11):997-1001. PubMed ID: 8582133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM.
    Doi Y; Yoshizumi H; Yoshinari M; Iino K; Yamamoto M; Ichikawa K; Iwase M; Fujishima M
    Diabetologia; 1996 Jan; 39(1):97-102. PubMed ID: 8720609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran.
    Rahimi Z; Hasanvand A; Felehgari V
    DNA Cell Biol; 2012 Apr; 31(4):553-9. PubMed ID: 21942443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus.
    Kvetny J; Gregersen G; Pedersen RS
    QJM; 2001 Feb; 94(2):89-94. PubMed ID: 11181984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin converting enzyme gene polymorphism and renal artery resistance in patients with insulin dependent diabetes mellitus.
    Fukumoto S; Ishimura E; Hosoi M; Kawagishi T; Kawamura T; Isshiki G; Nishizawa Y; Morii H
    Life Sci; 1996; 59(8):629-37. PubMed ID: 8761013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].
    Tarnow L; Parving HH; Jacobsen P; Rossing P; Lecerf L; Poirier O; Cambien F
    Ugeskr Laeger; 1998 Aug; 160(34):4886-9. PubMed ID: 9741257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus.
    Ilić V; Ilić M; Soldatović I; Popović S; Magić Z
    Vojnosanit Pregl; 2014 Jul; 71(7):627-33. PubMed ID: 25109108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.